Investigating antibody molecules for treating human diseases v1.0
Research type
Research Study
Full title
Use of human tissue to investigate novel antibody molecules for treating human diseases
IRAS ID
346726
Contact name
Elizabeth Hardaker
Contact email
Sponsor organisation
Epsilogen Ltd
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
5 years, 0 months, 1 days
Research summary
Antibody drugs are commonly used for the treatment of human diseases, such as cancer and autoimmune diseases. At Epsilogen Ltd we are generating novel antibody drugs to treat such diseases. To develop effective antibody drugs, human tissue is required to evaluate their functionality and biological mechanism of action. As such, at Epsilogen Ltd we require human tissue to perform in vitro experiments to assess pre-clinical antibody drug candidates for complete compound evaluation.
REC name
London - South East Research Ethics Committee
REC reference
24/PR/0880
Date of REC Opinion
22 Jul 2024
REC opinion
Favourable Opinion